CCR8 Targeted Antibody Immunotherapy Pipeline Review 2024: An Emerging, Highly Attractive Next Generation Immuno-oncology Target
July 08, 2024 04:08 ET
|
Research and Markets
Dublin, July 08, 2024 (GLOBE NEWSWIRE) -- The "CCR8-Targeted Antibody Immunotherapy Pipeline Review" report has been added to ResearchAndMarkets.com's offering. CCR8 is an emerging, highly...
Immuno-Oncology Research Advances: 2023 CCR8-Targeted Antibody Immunotherapy Pipeline Insights
December 14, 2023 05:38 ET
|
Research and Markets
Dublin, Dec. 14, 2023 (GLOBE NEWSWIRE) -- The "CCR8-Targeted Antibody Immunotherapy Pipeline Review" report has been added to ResearchAndMarkets.com's offering. A novel research publication...
Regulatory T-Cell Therapies Market, 2035
January 11, 2022 04:58 ET
|
Research and Markets
Dublin, Jan. 11, 2022 (GLOBE NEWSWIRE) -- The "Regulatory T-Cell Therapies Market by Target Indications, Key Players and Key Geographies: Industry Trends and Global Forecast, 2021-2035" report has...
Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Research & Developments, 2018-2020 & 2021-2026
December 17, 2021 07:38 ET
|
Research and Markets
Dublin, Dec. 17, 2021 (GLOBE NEWSWIRE) -- The "Current Research & Development Status of Chimeric Antigen Receptor (CAR) T-Cell Therapy" report has been added to ResearchAndMarkets.com's...